Skip to content
Disclosery

EXANE DERIVATIVES: DQ position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on DQ, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 4,654 DQ shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 4,654 shares
    Change vs previous 13F -1,278 shares

    0.19% of the 13F portfolio, value $332,141.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 5,932 shares
    Change vs previous 13F -327 shares

    0.07% of the 13F portfolio, value $245,091.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 6,259 shares
    Change vs previous 13F +50 shares

    0.06% of the 13F portfolio, value $252,352.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 6,209 shares
    Change vs previous 13F +1,245 shares

    0.09% of the 13F portfolio, value $353,882.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 4,964 shares
    Change vs previous 13F +2,966 shares

    0.08% of the 13F portfolio, value $359,137.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 1,998 shares
    Change vs previous 13F +302 shares

    0.05% of the 13F portfolio, value $150,842.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 1,696 shares
    Change vs previous 13F +1,482 shares

    0.03% of the 13F portfolio, value $97,278.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 214 shares
    Change vs previous 13F not available

    0.01% of the 13F portfolio, value $28,937.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).